BR9813598A - Derivado de tiazolidinediona substituìdo, processo para a sua preparação e seu uso farmacêutico - Google Patents

Derivado de tiazolidinediona substituìdo, processo para a sua preparação e seu uso farmacêutico

Info

Publication number
BR9813598A
BR9813598A BR9813598-8A BR9813598A BR9813598A BR 9813598 A BR9813598 A BR 9813598A BR 9813598 A BR9813598 A BR 9813598A BR 9813598 A BR9813598 A BR 9813598A
Authority
BR
Brazil
Prior art keywords
provides
preparation
compound
pharmaceutical use
here
Prior art date
Application number
BR9813598-8A
Other languages
English (en)
Inventor
Ian Robert Lynch
Bernadette Marie Choudary
Michael John Sasse
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9813598A publication Critical patent/BR9813598A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"DERIVADO DE TIAZOLIDINEDIONA SUBSTITUìDO, PROCESSO PARA A SUA PREPARAçãO E SEU USO FARMACêUTICO" Trata-se de um hidrato de sal de ácido malêico 5-[4- [2- (N-metil -N- (2-piridil) amino) etóxi] benzil] tiazolidina-2,4-diona, caracterizado pelo fato de que: (i) compreende água na faixa de 0,3 a 0,6 equivalente molar; e (ii) proporciona um espectro de infra vermelho que contêm picos a 1757, 1331, 1290, 1211 e 767 cm^ -1^; e/ou (iii) proporciona um espectro Raman que contêm picos a 1758, 1610, 1394,1316 e 1289 cm^ -1^; e/ou (iv) proporciona um espectro de ressonância nuclear magnética de estado sólido que contem desvios químicos substancialmente como determinado na Tabela I aqui; e/ou (v) proporciona um padrão de difração de potência de raio-X (XRPD) substancialmente conforme determinado na Figura IV aqui; um processo para a preparação do referido composto, uma composição farmacêutica que contêm o referido composto e o uso do referido composto ou composição em um medicamento.
BR9813598-8A 1997-12-16 1998-12-14 Derivado de tiazolidinediona substituìdo, processo para a sua preparação e seu uso farmacêutico BR9813598A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9726563.1A GB9726563D0 (en) 1997-12-16 1997-12-16 Novel pharmaceutical
PCT/EP1998/008153 WO1999031093A1 (en) 1997-12-16 1998-12-14 Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use

Publications (1)

Publication Number Publication Date
BR9813598A true BR9813598A (pt) 2000-10-10

Family

ID=10823691

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9813598-8A BR9813598A (pt) 1997-12-16 1998-12-14 Derivado de tiazolidinediona substituìdo, processo para a sua preparação e seu uso farmacêutico

Country Status (37)

Country Link
US (4) US20020133016A1 (pt)
EP (1) EP1042321A1 (pt)
JP (1) JP2002508371A (pt)
KR (1) KR100549141B1 (pt)
CN (3) CN101318956A (pt)
AP (1) AP1363A (pt)
AR (2) AR017211A1 (pt)
AU (2) AU2272299A (pt)
BG (1) BG64850B1 (pt)
BR (1) BR9813598A (pt)
CA (1) CA2314967A1 (pt)
CO (1) CO4990943A1 (pt)
CZ (1) CZ300081B6 (pt)
DZ (1) DZ2679A1 (pt)
EA (1) EA002833B1 (pt)
EG (1) EG22250A (pt)
GB (1) GB9726563D0 (pt)
HR (1) HRP20000404A2 (pt)
HU (1) HUP0102292A3 (pt)
ID (1) ID24714A (pt)
IL (2) IL136425A (pt)
MA (1) MA26581A1 (pt)
MY (1) MY128573A (pt)
NO (1) NO317255B1 (pt)
NZ (1) NZ504703A (pt)
OA (1) OA11900A (pt)
PE (1) PE20000125A1 (pt)
PL (1) PL341213A1 (pt)
RS (1) RS50080B (pt)
SA (1) SA99200200B1 (pt)
SK (1) SK286422B6 (pt)
TR (2) TR200001793T2 (pt)
TW (1) TW487709B (pt)
UA (1) UA66821C2 (pt)
UY (2) UY25309A1 (pt)
WO (1) WO1999031093A1 (pt)
ZA (1) ZA9811504B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US20020137940A1 (en) * 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
OA11871A (en) * 1999-04-23 2006-03-27 Smithkline Beecham Plc Novel pharmaceutical.
PE20010045A1 (es) * 1999-04-23 2001-03-10 Smithkline Beecham Plc Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidin-2,4-diona
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
ES2203453T3 (es) * 1999-04-23 2004-04-16 Smithkline Beecham Plc Polimorfo de sal del acido maleico de 5-(4-(2-(n-metil-n-(2-piridil)amino)etoxi)bentil)tiazolidina-2,4-diona.
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
GB0021784D0 (en) * 2000-09-05 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
GB0021978D0 (en) * 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
WO2003050112A1 (en) * 2001-12-13 2003-06-19 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
EP1468997A3 (en) * 2003-04-18 2004-11-03 CHEMI S.p.A. Polymorphous forms of rosiglitazone maleate
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
WO2005065654A2 (en) * 2003-12-31 2005-07-21 Alpharma, Inc. Rosiglitazone formulations
US20050163842A1 (en) * 2003-12-31 2005-07-28 Garth Boehm Rosiglitazone and metformin formulations
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
EP2184055A1 (en) 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Process for preparing solid dosage forms of rosiglitazone maleate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
US6288095B1 (en) * 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
GB8820389D0 (en) * 1988-08-26 1988-09-28 Beecham Group Plc Novel compounds
GB9124513D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
SG47100A1 (en) * 1994-02-10 1998-03-20 Smithkline Beecham Plc Use of insulin sensitisers for treating renal diseases
DE4404198A1 (de) 1994-02-10 1995-08-17 Henkel Kgaa 2-Fluor-6-nitroaniline
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
EP1322647A1 (en) 2000-09-26 2003-07-02 Dr. Reddy's Research Foundation Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt and process for their preparation

Also Published As

Publication number Publication date
YU36400A (sh) 2003-12-31
IL136425A (en) 2004-08-31
AU770818B2 (en) 2004-03-04
US20030139604A1 (en) 2003-07-24
DZ2679A1 (fr) 2003-03-29
UA66821C2 (uk) 2004-06-15
HUP0102292A3 (en) 2003-12-29
EP1042321A1 (en) 2000-10-11
GB9726563D0 (en) 1998-02-11
PL341213A1 (en) 2001-03-26
CZ300081B6 (cs) 2009-01-28
AP1363A (en) 2005-01-21
US20020133016A1 (en) 2002-09-19
US20070037859A1 (en) 2007-02-15
CZ20002206A3 (cs) 2000-12-13
TR199802624A2 (xx) 1999-10-21
UY25306A1 (es) 2000-12-29
RS50080B (sr) 2009-01-22
US20050288513A1 (en) 2005-12-29
EA002833B1 (ru) 2002-10-31
WO1999031093A1 (en) 1999-06-24
HRP20000404A2 (en) 2000-12-31
ZA9811504B (en) 2000-06-15
AU2753802A (en) 2002-05-16
IL136425A0 (en) 2001-06-14
CA2314967A1 (en) 1999-06-24
SK286422B6 (sk) 2008-09-05
ID24714A (id) 2000-08-03
PE20000125A1 (es) 2000-03-03
KR20010033140A (ko) 2001-04-25
AR016161A1 (es) 2001-06-20
AU2272299A (en) 1999-07-05
CN101318957A (zh) 2008-12-10
BG104606A (en) 2001-02-28
NO20003070D0 (no) 2000-06-15
CN101318956A (zh) 2008-12-10
JP2002508371A (ja) 2002-03-19
KR100549141B1 (ko) 2006-02-03
UY25309A1 (es) 1999-07-19
SK9182000A3 (en) 2000-12-11
NO20003070L (no) 2000-06-15
MA26581A1 (fr) 2004-12-20
NZ504703A (en) 2002-12-20
TR199802624A3 (tr) 1999-10-21
SA99200200B1 (ar) 2006-11-11
IL160847A0 (en) 2004-08-31
US7368574B2 (en) 2008-05-06
AR017211A1 (es) 2001-08-22
MY128573A (en) 2007-02-28
EA200000656A1 (ru) 2000-12-25
NO317255B1 (no) 2004-09-27
HUP0102292A2 (hu) 2002-05-29
TW487709B (en) 2002-05-21
OA11900A (en) 2006-04-10
EG22250A (en) 2002-11-30
CO4990943A1 (es) 2000-12-26
AP2000001829A0 (en) 2000-06-30
CN1285831A (zh) 2001-02-28
TR200001793T2 (tr) 2000-10-23
BG64850B1 (bg) 2006-06-30

Similar Documents

Publication Publication Date Title
BR9813598A (pt) Derivado de tiazolidinediona substituìdo, processo para a sua preparação e seu uso farmacêutico
BR9813600A (pt) Hidrato de sal de ácido malêico 5-[4-[2-(n-metil-n-(2-piridil) amino) etóxi]benzil]tiazolidina-2,4-diona como farmacêutico
IL78831A (en) 6-(thiazolidin-2,4-dion-5-ylmethyl)chromans and structurally related compounds as hypoglycemic agents
BR0009934A (pt) Produto farmacêutico
BR9813604A (pt) Hidrato de sal de ácido maleico 5-[4-[2- (n-metil-n-(2-piridil) amino) etóxi]benzil]tiazolidina-2,4-diona
BR0009932A (pt) Polimorfo de sal de ácido maléico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etóxi]benzil]tiazolidi na-2,4-diona
AP1607A (en) Thiazolidinedione derivative and its use as antidiabetic.
DK500985D0 (da) Heterocykliske derivater, farmaceutiske praeparater indeholdende disse, deres anvendelse ved behandlingen af histaminformidlede tilstandei hjernen samt fremgangsmaader til deres fremstilling
EA200101101A1 (ru) Новый фармацевтический препарат
ECSP034505A (es) La sal de clorhidrato de 5-[4-(2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2, 4-diona
EA200101102A1 (ru) Новый фармацевтический препарат
ID30064A (id) Kristal-kristal 5[(2-fluorobenzil) oksi-2-naftil) metil]-2, 4-tiazolidinedion
ECSP982779A (es) Un hidrato de la sal de acido maleico, proceso para la preparacion, composicion farmaceutica y su uso en medicina
DK126989A (da) Benzo(b)thiophenderivater samt deres fremstilling og anvendelse
ECSP982781A (es) Hidrato de la sal de maleico de 5-[4- (-n -metil-n- (2-piridil) amino) etoxi) bensil) tiazolidina - 2,4 diona
ECSP003434A (es) Nuevos compuestos
ECSP003435A (es) Nuevos compuestos
ECSP003438A (es) Nuevos compuestos
ECSP982780A (es) Nuevo producto farmaceutico proceso para su preparacion y su uso en medicina
ECSP003436A (es) Nuevos compuestos

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO COM BASE NOS ARTIGOS 8O, 11 E 13 DA LEI 9279/96